Literature DB >> 20665398

Quality of life in sarcoidosis: assessment and management.

Jolanda De Vries1, Elyse E Lower, Marjolein Drent.   

Abstract

This review focuses on current knowledge of the QOL (quality of life) and HS (health status) of sarcoidosis patients. The QOL and HS of sarcoidosis patients are impaired and symptoms are a cause of this impairment. Fatigue appears to be the major problem in sarcoidosis patients. QOL is a concept that concerns patients' evaluation of their functioning in a wide range of domains, but always the physical, psychological, and social domain. HS concerns patients' physical, psychological, and social functioning. There are a number of HS questionnaires and one QOL measure that have shown useful in sarcoidosis. In addition, there exists one sarcoidosis-specific HS measure. The main symptom of fatigue can be assessed reliably and valid with the Fatigue Assessment Scale. The absence of objective parameters for experiencing impairment does not always mean that patients are healthy. Because what patients can handle is clearly decreased, the activities should be adapted accordingly. Present studies are generally cross-sectional. There is a need for prospective follow-up studies assessing the natural course of patients' disease in relation to symptoms and QOL. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20665398     DOI: 10.1055/s-0030-1262216

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  7 in total

Review 1.  Patient reported outcome measures (PROMs) in sarcoidosis.

Authors:  Rikke Flor Thunold; Anders Løkke; Adam Langballe Cohen; Hilberg Ole; Elisabeth Bendstrup
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 2.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

3.  Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis.

Authors:  David E Victorson; Seung Choi; Marc A Judson; David Cella
Journal:  Qual Life Res       Date:  2013-11-09       Impact factor: 4.147

4.  Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.

Authors:  Misha Rosenbach; Howa Yeung; Emily Y Chu; Ellen J Kim; Aimee S Payne; Junko Takeshita; Carmela C Vittorio; Karolyn A Wanat; Victoria P Werth; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

5.  A conceptual model of health-related quality of life in sarcoidosis.

Authors:  David E Victorson; David Cella; Heidi Grund; Marc A Judson
Journal:  Qual Life Res       Date:  2013-05-26       Impact factor: 4.147

6.  Distance saturation product predicts health-related quality of life among sarcoidosis patients.

Authors:  Julie M Bourbonnais; Subramanian Malaisamy; Bhavinkumar D Dalal; Priyan C Samarakoon; Swapna R Parikh; Lobelia Samavati
Journal:  Health Qual Life Outcomes       Date:  2012-06-13       Impact factor: 3.186

Review 7.  Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.

Authors:  Marc A Judson
Journal:  F1000Res       Date:  2019-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.